Pathogenic Bacteria and Fungi: Virulence, Antimicrobial Resistance, and Modern Strategies for Diagnosis and Control (2020–2026)

Authors

DOI:

https://doi.org/10.55892/jrg.v9i20.2844

Keywords:

Antimicrobial resistance, Microbial virulence, Biofilms, Pathogenic fungi

Abstract

Pathogenic bacteria and fungi represent structural challenges to global health and food security, driven by increasing antimicrobial resistance and the complexity of their virulence mechanisms. This narrative review  analyzes the emergence of these agents under the One Health perspective, detailing biological strategies such as biofilm formation, phenotypic plasticity, and horizontal gene transfer that sustain persistence in clinical and productive environments. The critical impact of priority pathogens (such as Candida auris and multidrug-resistant bacteria) and therapeutic scarcity, especially antifungal, aggravated by environmental selective pressure, are discussed. The study also evaluates diagnostic advances, highlighting metagenomics (mNGS) and genomic surveillance as decisive tools for traceability and outbreak control. It is concluded that mitigating these threats depends on the integration of technological innovation, rapid diagnostics, and robust health governance, essential to preserve therapeutic efficacy and the sustainability of health systems.

Downloads

Download data is not yet available.

Author Biography

Charlys Seixas Maia Dornelas, Universidade Federal da Paraíba, PB, Brasil

Graduado em Medicina Veterinária. Mestre em Zootecnia, Doutor em Agronomia.

References

BURKI, T. K. Fungal priority pathogens list. The Lancet Microbe, DOI: 10.1016/S2666-5247(23)00003-4.2023

CASADEVALL, A. Host-pathogen interactions and the pathogenesis of infectious diseases: a perspective. Virulence. DOI: 10.1080/21505594.2025.2547090. 2025

CHEUNG, G. Y. C.; BAE, J. S.; OTTO, M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. DOI: 10.1080/21505594.2021.1878688.2021

CHOWDHARY, A. et al. Candida auris: a rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally. Nature Reviews Microbiology. DOI: 10.1038/s41579-021-00538-5. 2021

CIUREA, C. N. et al. Candida and candidiasis—opportunism, pathogenicity, host immune response, and microbiota. Microorganisms,. DOI: 10.3390/microorganisms8060857. 2020

CORTEGIANI, A. et al. Candida auris: epidemiology, clinical characteristics, resistance, and management. The Lancet Microbe. DOI: 10.1016/S2666-5247(23)00114-3. 2023

FISHER, M. C. et al. Threats posed by the fungal kingdom to humans, wildlife, and agriculture. mBio. DOI: 10.1128/mBio.00449-20. 2020

FISHER, M. C.; DENNING, D. W. The worldwide priority of fungal pathogens. Nature Reviews Microbiology. DOI: 10.1038/s41579-023-00861-x. 2023

GARNICA, M. et al. Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia. The Brazilian Journal of Infectious Diseases. DOI: 10.1016/j.bjid.2021.101548. 2021

MURRAY, C. J. L. et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. DOI: 10.1016/S0140-6736(21)02724-0. 2022

MURRAY, C. J. L. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis. The Lancet. DOI: 10.1016/S0140-6736(24)01867-1. 2024

NOURI, R. et al. CRISPR-based detection of infectious diseases: a review. Nature Biomedical Engineering. DOI: 10.1038/s41551-021-00760-7. 2021

POIREL, L. et al. Plasmid-mediated colistin resistance genes: mcr. Trends in Microbiology. DOI: 10.1016/j.tim.2023.10.006. 2024

QIN, S. et al. Emerging understanding of Pseudomonas aeruginosa pathogenesis and virulence factors. Signal Transduction and Targeted Therapy. DOI: 10.1038/s41392-022-01056-1. 2022

RODRÍGUEZ-CERDEIRA, C. et al. Candida infections: an update on epidemiology, pathogenesis, diagnosis and treatment. Frontiers in Microbiology. DOI: 10.3389/fmicb.2020.544480. 2020

RODRIGUES, M. E. et al. Fungal biofilms and polymicrobial disease. Journal of Fungi,. DOI: 10.3390/jof7080603. 2021

SACHDEVA, S. et al. Metabolic allies or adversaries: bacterial and fungal interactions shaping pathogenicity. Critical Reviews in Microbiology,. DOI: 10.1080/1040841X.2024.2397359. 2024

SATALA, D. et al. Antifungal resistance in biofilm-associated infections. Frontiers in Cellular and Infection Microbiology. DOI: 10.3389/fcimb.2021.765942. 2022

SCHIMMER, J. et al. Clinical metagenomic sequencing for pathogen detection: applications and considerations. Frontiers in Cellular and Infection Microbiology. DOI: 10.3389/fcimb.2024.1458316. 2024

THORPE, H. A. et al. Deep sequencing for infection prevention and control in healthcare. The Lancet Microbe. DOI: 10.1016/S2666-5247(24)00113-7. 2024

UDDIN, T. M. et al. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. Journal of Infection and Public Health. DOI: 10.1016/j.jiph.2021.10.020. 2021

VERWEIJ, P. E. et al. Azole resistance in Aspergillus fumigatus: a global public health issue. mBio. DOI: 10.1128/mbio.01871-20. 2021

WORLD HEALTH ORGANIZATION. WHO bacterial priority pathogens list: 2024 update. The Lancet Infectious Diseases. DOI: 10.1016/S1473-3099(25)00118-5. 2025

Published

2026-01-23

How to Cite

DORNELAS, C. S. M. Pathogenic Bacteria and Fungi: Virulence, Antimicrobial Resistance, and Modern Strategies for Diagnosis and Control (2020–2026) . JRG Journal of Academic Studies, Brasil, São Paulo, v. 9, n. 20, p. e092844, 2026. DOI: 10.55892/jrg.v9i20.2844. Disponível em: http://revistajrg.com/index.php/jrg/article/view/2844. Acesso em: 25 jan. 2026.

ARK